PRESS DIGEST- Financial Times - Oct. 16

Headlines Remdesivir has little effect on COVID-19 mortality, WHO study says https://on.ft.com/3o3mh0j Johnson ready to force Brexit crisis with no-deal ultimatum https://on.ft.com/2IAkZtj Marston's to cut 2,150 jobs after UK clampdown on hospitality sector https://on.ft.com/2H6D6pV Overview Gilead Sciences Inc's remdesivir has no substantial effect on a patient's chances of survival, a clinical trial by the World Health Organization has found.

The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines

Remdesivir has little effect on COVID-19 mortality, WHO study says https://on.ft.com/3o3mh0j Johnson ready to force Brexit crisis with no-deal ultimatum https://on.ft.com/2IAkZtj

Marston's to cut 2,150 jobs after UK clampdown on hospitality sector https://on.ft.com/2H6D6pV Overview

Gilead Sciences Inc's remdesivir has no substantial effect on a patient's chances of survival, a clinical trial by the World Health Organization has found. British Prime Minister Boris Johnson might try to force Brexit trade talks to a moment of crisis on Friday, as he was "disappointed" with the outcome of a recent European Council meeting, and amid claims that Brussels is dragging its feet by insisting that future concessions must come from the British side. Pub operator Marston's, is to cut 2,150 furloughed jobs after a swath of new government restrictions designed to curb the spread of coronavirus caused sales to slump.

(Compiled by Bengaluru newsroom)